Carbamazepine Capsule, Extended Release
Product Images NDC 67046-1559

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbamazepine (NDC 67046-1559). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Coupler Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 mg Capsule Bottle Label)

Principal Display Panel (100 mg Capsule Bottle Label)
This text appears to contain information about a medication called Carbamazepine, with each capsule containing 100 mg of the active ingredient. The usual dosage should be followed as directed by a physician, and further details can be found in the attached prescribing information brochure. The medication should be stored at a temperature between 15°C to 30°C and protected from light and moisture. There are warnings included about keeping the medication out of reach of children and not using it with other carbamazepine-containing products. Pharmacies are advised to dispense the medication in a tight container and provide patients with a medication guide. Additionally, there is contact information provided for obtaining the medication guide.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Principal Display Panel (200 mg Capsule Bottle Label)
Each capsule contains 200 mg of Carbamazepine. The usual dosage should be followed as directed by a healthcare professional. These are extended-release capsules that should be stored at a temperature range of 20° to 25°C. It is important to protect them from light and moisture. The medication should not be used with other Carbamazepine-containing products. Keep this medication out of reach of children and dispense it in a USP container. A warning advises users to keep all medications out of reach of children. Additionally, there is a recommendation to dispense an accompanying medication guide to each patient. This product is available in a package of 120 capsules.*
FDA Label Image

Principal Display Panel (200 mg Capsule Bottle Label)

Principal Display Panel (200 mg Capsule Bottle Label)
The text is describing a medication containing 300 mg of Carbamazepine, USP in each capsule with NDC 29033-004-12. The usual dosage should be followed as directed by a physician. It also mentions the importance of protecting the medication from light and moisture and advises against using it with other carbamazepine-containing products. The warning given is to keep the medication out of reach of children. Additionally, it suggests dispensing the accompanying Medication Guide to each patient.*
FDA Label Image

Carba-structure (Carba Struc)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.